Conversely, inhibition of MEK and BRAF in combination has very little impact on Ras/RAF/MEK/ERK signaling in RAS mutant A375 melanoma cells, as activating RAS mutations operate upstream of both MEK and BRAF in this signaling pathway. This evidence concerns the gene BRAF and melanoma.